Back to Search
Start Over
Supplementary Table 1 from Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file - 50K, Primers for KIT gene mutation testing.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....9226ecc2eccc4b8fe30a449ca144fbf5